Investment
Features
FeesSafety
Academy
More
Pluang+

Compare BIO-TECHNE Corp (TECH) vs United Airlines Holdings Inc (UAL) Price & Performance

BIO-TECHNE CorpTrade
United Airlines Holdings IncTrade

Price performance (Past 24H)

Key statistics

BIO-TECHNE Corp vs United Airlines Holdings Inc — how do they compare? BIO-TECHNE Corp trades at $72.46 (market cap $11.37B), while United Airlines Holdings Inc trades at $108.53 (market cap $35.76B). The key difference: United Airlines Holdings Inc is far larger — about 3.1× BIO-TECHNE Corp's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while United Airlines Holdings Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold BIO-TECHNE Corp for 63 Days and United Airlines Holdings Inc for 46 Days on average.

TECHUAL
Market Cap
$11.37B$35.76B
Volume
3,153,5115,327,551
Sector
HealthIndustrials
52-Week High
$72.61$136.11
52-Week Low
$43.31$85.21
Typical Hold Time
63 Days46 Days
Enterprise Value
$11.40B$52.79B
Dividend Yield
0.44%—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

BIO-TECHNE Corp

TECH trades at $72.53, near its 52-week high of $72.70, with a bullish technical signal and strong institutional interest. Recent earnings show mixed results, beating in Q2 2026 but missing in Q1. The company maintains solid profitability with a 65.77% gross margin, though net income declined to $73.40M in 2025. Shareholders approved an acquisition by Merck KGaA at $73.00 per share, a key near-term catalyst.

Outlook is positive due to the pending acquisition, but risks include execution challenges and valuation concerns with a high P/E of 62.53. Analyst consensus is divided with 46% buy ratings, suggesting cautious optimism. The stock offers limited upside to the acquisition price, making it suitable for event-driven investors.

United Airlines Holdings Inc

United Airlines (UAL) trades at $110.17, down 1.53% on the day, with a bearish technical signal from moving averages. The stock shows strong fundamentals with a low P/E of 10.32 and consistent earnings beats, including Q2 2026 EPS of $1.99 versus $1.88 expected. Revenue growth has climbed from $45.0B in 2022 to $59.1B in 2025, with net income margin improving to 5.67%. Recent news highlights aggressive customer acquisition efforts targeting Delta's premium flyers.

The outlook is mixed: analyst consensus is strongly bullish with a $158.10 price target and no sell ratings, but technical indicators and rising fuel costs pose near-term risks. Earnings sustainability and market share gains from competitor targeting present upside, while debt levels and operational volatility remain challenges for shareholder value.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

TECH

No sentiment data available yet.

UAL
0% Buy100% Sell
Avg holding period · 46 Days

Top news

Latest headlines on both assets

About BIO-TECHNE Corp

Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.

Read more on TECH →

About United Airlines Holdings Inc

United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.

Read more on UAL →